Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

ARF1 Inhibitors

ADP-Ribosylation Factor 1 (ARF1) is a small GTPase that plays a critical role in vesicle trafficking within the cells, particularly in the Golgi apparatus and the endoplasmic reticulum. ARF1 is involved in the formation of vesicles by promoting the assembly of coat protein complexes on the Golgi membrane, thereby facilitating the transport of proteins and lipids between the Golgi and other cellular compartments. This process is crucial for maintaining cellular homeostasis and for the proper functioning of intracellular signaling pathways. The activation of ARF1 is tightly regulated by the cycle of GTP binding and hydrolysis, which is mediated by guanine nucleotide exchange factors (GEFs) that activate ARF1 by promoting the exchange of GDP for GTP, and GTPase-activating proteins (GAPs) that inactivate ARF1 by accelerating GTP hydrolysis. The precise control of ARF1 activity is essential for the fidelity of vesicular trafficking and has implications for various cellular processes, including cell division, differentiation, and response to external signals. The inhibition of ARF1's activity involves mechanisms that interfere with its GTP-binding and hydrolysis cycle or its interaction with other proteins necessary for its function. Inhibitors can target ARF1 directly by binding to the GTPase and blocking its interaction with GEFs, thereby blocking the activation process. Alternatively, molecules that mimic the structure of GTP or GDP can bind to ARF1, leading to an inactive state of the protein that is incapable of participating in vesicle formation. Inhibition can also occur through the disruption of the interaction between ARF1 and its effector proteins, which are necessary for the recruitment of coat proteins to membranes. Moreover, the modulation of the expression levels of ARF1, GEFs, or GAPs through genetic or epigenetic mechanisms represents another approach to indirectly inhibit ARF1 activity. Understanding the mechanisms of ARF1 inhibition provides insights into the regulation of intracellular transport and its impact on cellular physiology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$191.00
$683.00
11
(1)

Golgicide A acts as a potent inhibitor of ARF1 by specifically targeting its guanine nucleotide exchange factor (GEF) interactions. This compound disrupts the activation cycle of ARF1, leading to altered vesicular transport and Golgi apparatus integrity. Its unique structural features allow for selective binding, influencing the kinetics of ARF1-mediated membrane dynamics. By modulating these interactions, Golgicide A plays a critical role in cellular organization and trafficking pathways.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts the function of the guanine nucleotide exchange factor (GEF) for ARF1, inhibiting ARF1 activation. This leads to the prevention of vesicle formation and trafficking, impacting cellular processes dependent on ARF1-mediated vesicular transport.

SecinH3

853625-60-2sc-203260
5 mg
$278.00
6
(1)

Blocks the activity of the ARF guanine nucleotide exchange factor (ARF GEF), inhibiting ARF1 activation. This inhibition disrupts the normal functioning of ARF1 in vesicle formation and trafficking, impacting cellular processes reliant on ARF1-mediated intracellular transport.

Exo2

304684-77-3sc-215011
sc-215011A
5 mg
25 mg
$89.00
$288.00
1
(0)

Inhibits ARF1 activation by targeting the ARF guanine nucleotide exchange factor (ARF GEF). By disrupting the ARF1-GTP cycle, Exo2 interferes with vesicle formation and trafficking, influencing cellular processes dependent on ARF1-mediated intracellular transport.

Wnt Synergist, QS11

944328-88-5sc-222417
sc-222417A
5 mg
25 mg
$141.00
$607.00
(1)

Inhibits ARF1 activation by disrupting the function of the ARF guanine nucleotide exchange factor (ARF GEF). This interference with the ARF1-GTP cycle impacts vesicle formation and trafficking, affecting cellular processes reliant on ARF1-mediated intracellular transport.